Hyaluronate and Derivatives and Omadacycline oral/injection
Determining the interaction of Hyaluronate and Derivatives and Omadacycline oral/injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Omadacycline Tablets
- Hyaluronate and Derivatives-Omadacycline Tosylate
- Hyaluronate and Derivatives-Omalizumab
- Hyaluronate and Derivatives-Omalizumab Subcutaneous
- Hyaluronate and Derivatives-Ombitasvir, Paritaprevir, and Ritonavir
- Hyaluronate and Derivatives-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Omadacycline oral/injection-Hyaluronate and Derivatives Injection (Knee)
- Omadacycline oral/injection-Hyaluronate sodium Injection
- Omadacycline oral/injection-Hyaluronidase
- Omadacycline oral/injection-Hyaluronidase and immune globulin
- Omadacycline oral/injection-Hyaluronidase and rituximab
- Omadacycline oral/injection-Hyaluronidase and trastuzumab